Meyers James R
Insider CIK 1387521 · SGMO Director · ABUS Director · CTMX Director · VERA Director · GILD EVP Worldwide Commercial Ops
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 59,000 | — | $0 | 59,000 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2026-05-21 | 2026-05-26 | 17,084 | — | $0 | 17,084 | SEC↗ |
| VERA Vera Therapeutics, Inc. | A Award deriv | 2025-11-25 | 2025-11-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2025-06-12 | 2025-06-16 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2025-06-12 | 2025-06-16 | 25,000 | — | $0 | 99,600 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2024-06-04 | 2024-06-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2024-06-04 | 2024-06-06 | 25,000 | — | $0 | 74,600 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2024-05-23 | 2024-05-24 | 67,000 | — | $0 | 67,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2024-05-15 | 2024-05-17 | 38,000 | — | $0 | 38,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2023-06-01 | 2023-06-05 | 27,750 | — | $0 | 27,750 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2023-06-01 | 2023-06-05 | 13,900 | — | $0 | 49,600 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2023-05-24 | 2023-05-26 | 55,000 | — | $0 | 55,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2022-05-25 | 2022-05-26 | 41,000 | — | $0 | 41,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2022-02-25 | 2022-03-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2022-02-25 | 2022-03-01 | 12,500 | — | $0 | 35,700 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2021-06-03 | 2021-06-07 | 22,000 | — | $0 | 22,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2021-02-25 | 2021-03-01 | 16,400 | — | $0 | 16,400 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2021-02-25 | 2021-03-01 | 8,200 | — | $0 | 23,200 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2020-06-17 | 2020-06-19 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2020-05-28 | 2020-06-01 | 22,000 | — | $0 | 22,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2020-05-18 | 2020-05-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2020-05-18 | 2020-06-03 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2020-05-18 | 2020-05-20 | 2,500 | — | $0 | 7,500 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2020-05-18 | 2020-06-03 | 10,000 | — | $0 | 15,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award deriv | 2019-11-22 | 2019-11-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SGMO SANGAMO THERAPEUTICS, INC | A Award | 2019-11-22 | 2019-11-26 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2019-08-17 | 2019-08-20 | 22,000 | — | $0 | 22,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2019-06-19 | 2019-06-21 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CTMX CytomX Therapeutics, Inc. | A Award deriv | 2018-12-20 | 2018-12-27 | 28,000 | — | $0 | 28,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2018-10-18 | 2018-10-22 | 44,000 | — | $0 | 44,000 | SEC↗ |
| GILD GILEAD SCIENCES INC | A Award | 2018-02-21 | 2018-02-23 | 4,846 | — | $0 | 7,782 | SEC↗ |
| GILD GILEAD SCIENCES INC | A Award | 2018-02-21 | 2018-02-23 | 1,581 | — | $0 | 9,363 | SEC↗ |
| GILD GILEAD SCIENCES INC | F Tax w/h | 2018-02-21 | 2018-02-23 | 1,647 | $80.69 | $132.9K | 7,716 | SEC↗ |
| GILD GILEAD SCIENCES INC | G Gift | 2018-02-21 | 2018-02-23 | 2,323 | — | $0 | 5,393 | SEC↗ |
| GILD GILEAD SCIENCES INC | G Gift | 2018-02-21 | 2018-02-23 | 2,323 | — | $0 | 132,083 | SEC↗ |
| GILD GILEAD SCIENCES INC | A Award | 2018-02-15 | 2018-02-23 | 221 | $62.35 | $13.8K | 2,936 | SEC↗ |
| GILD GILEAD SCIENCES INC | A Award deriv | 2018-02-01 | 2018-02-05 | 75,490 | — | $0 | 75,490 | SEC↗ |
| GILD GILEAD SCIENCES INC | M Exercise deriv | 2018-01-16 | 2018-01-18 | 100,000 | — | $0 | 0 | SEC↗ |
| GILD GILEAD SCIENCES INC | S Sale | 2018-01-16 | 2018-01-18 | 75,157 | $80.00 | $6.01M | 27,558 | SEC↗ |
| GILD GILEAD SCIENCES INC | S Sale | 2018-01-16 | 2018-01-18 | 24,843 | $80.99 | $2.01M | 2,715 | SEC↗ |
| GILD GILEAD SCIENCES INC | M Exercise | 2018-01-16 | 2018-01-18 | 100,000 | $21.58 | $2.16M | 102,715 | SEC↗ |
| GILD GILEAD SCIENCES INC | G Gift | 2017-11-09 | 2017-11-13 | 1,327 | — | $0 | 129,760 | SEC↗ |
| GILD GILEAD SCIENCES INC | A Award | 2017-11-09 | 2017-11-13 | 2,700 | — | $0 | 5,415 | SEC↗ |
| GILD GILEAD SCIENCES INC | F Tax w/h | 2017-11-09 | 2017-11-13 | 1,373 | $73.02 | $100.3K | 4,042 | SEC↗ |
| GILD GILEAD SCIENCES INC | G Gift | 2017-11-09 | 2017-11-13 | 1,327 | — | $0 | 2,715 | SEC↗ |
| GILD GILEAD SCIENCES INC | M Exercise deriv | 2017-11-05 | 2017-11-07 | 4,500 | — | $0 | 4,460 | SEC↗ |
| GILD GILEAD SCIENCES INC | F Tax w/h | 2017-11-05 | 2017-11-07 | 2,212 | $73.46 | $162.5K | 5,003 | SEC↗ |
| GILD GILEAD SCIENCES INC | G Gift | 2017-11-05 | 2017-11-07 | 2,288 | — | $0 | 128,433 | SEC↗ |
| GILD GILEAD SCIENCES INC | G Gift | 2017-11-05 | 2017-11-07 | 2,288 | — | $0 | 2,715 | SEC↗ |
| GILD GILEAD SCIENCES INC | M Exercise | 2017-11-05 | 2017-11-07 | 4,500 | — | $0 | 7,215 | SEC↗ |
| GILD GILEAD SCIENCES INC | M Exercise deriv | 2017-08-31 | 2017-09-05 | 60,000 | — | $0 | 0 | SEC↗ |
| GILD GILEAD SCIENCES INC | S Sale | 2017-08-31 | 2017-09-05 | 43,300 | $83.01 | $3.59M | 19,415 | SEC↗ |
| GILD GILEAD SCIENCES INC | M Exercise | 2017-08-31 | 2017-09-05 | 60,000 | $21.00 | $1.26M | 62,715 | SEC↗ |
| GILD GILEAD SCIENCES INC | S Sale | 2017-08-31 | 2017-09-05 | 16,700 | $83.64 | $1.40M | 2,715 | SEC↗ |
| GILD GILEAD SCIENCES INC | G Gift | 2017-08-15 | 2017-08-31 | 115 | — | $0 | 126,145 | SEC↗ |
| GILD GILEAD SCIENCES INC | A Award | 2017-08-15 | 2017-08-31 | 115 | $59.76 | $6.9K | 2,830 | SEC↗ |
| GILD GILEAD SCIENCES INC | G Gift | 2017-08-15 | 2017-08-31 | 115 | — | $0 | 2,715 | SEC↗ |
| GILD GILEAD SCIENCES INC | M Exercise deriv | 2017-08-10 | 2017-08-14 | 820 | — | $0 | 8,960 | SEC↗ |
| GILD GILEAD SCIENCES INC | G Gift | 2017-08-10 | 2017-08-14 | 525 | — | $0 | 2,715 | SEC↗ |
| GILD GILEAD SCIENCES INC | M Exercise | 2017-08-10 | 2017-08-14 | 820 | — | $0 | 3,535 | SEC↗ |
| GILD GILEAD SCIENCES INC | F Tax w/h | 2017-08-10 | 2017-08-14 | 295 | $72.70 | $21.4K | 3,240 | SEC↗ |
| GILD GILEAD SCIENCES INC | G Gift | 2017-08-10 | 2017-08-14 | 525 | — | $0 | 126,030 | SEC↗ |
| GILD GILEAD SCIENCES INC | G Gift | 2017-02-16 | 2017-02-21 | 4,354 | — | $0 | 125,505 | SEC↗ |
| GILD GILEAD SCIENCES INC | G Gift | 2017-02-16 | 2017-02-21 | 4,354 | — | $0 | 2,715 | SEC↗ |
| GILD GILEAD SCIENCES INC | A Award | 2017-02-16 | 2017-02-21 | 1,161 | — | $0 | 8,100 | SEC↗ |
| GILD GILEAD SCIENCES INC | F Tax w/h | 2017-02-16 | 2017-02-21 | 2,053 | $70.31 | $144.3K | 7,069 | SEC↗ |
| GILD GILEAD SCIENCES INC | A Award | 2017-02-16 | 2017-02-21 | 1,022 | — | $0 | 9,122 | SEC↗ |
| GILD GILEAD SCIENCES INC | A Award | 2017-02-15 | 2017-02-21 | 213 | $59.33 | $12.6K | 6,939 | SEC↗ |
| GILD GILEAD SCIENCES INC | A Award deriv | 2017-02-02 | 2017-02-06 | 42,390 | — | $0 | 42,390 | SEC↗ |
| GILD GILEAD SCIENCES INC | A Award deriv | 2016-12-10 | 2016-12-13 | 28,040 | — | $0 | 28,040 | SEC↗ |